19-57620444-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_003435.5(ZNF134):​c.325G>A​(p.Asp109Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 1,614,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

ZNF134
NM_003435.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.308
Variant links:
Genes affected
ZNF134 (HGNC:12918): (zinc finger protein 134) Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.057181776).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ZNF134NM_003435.5 linkuse as main transcriptc.325G>A p.Asp109Asn missense_variant 3/3 ENST00000396161.10 NP_003426.3 P52741-1Q5U5N5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ZNF134ENST00000396161.10 linkuse as main transcriptc.325G>A p.Asp109Asn missense_variant 3/31 NM_003435.5 ENSP00000379464.4 P52741-1
ZNF134ENST00000597975.1 linkuse as main transcriptn.556G>A non_coding_transcript_exon_variant 2/21

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152164
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000168
AC:
42
AN:
249586
Hom.:
0
AF XY:
0.000214
AC XY:
29
AN XY:
135408
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.000203
AC:
297
AN:
1461892
Hom.:
0
Cov.:
32
AF XY:
0.000205
AC XY:
149
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000268
Gnomad4 ASJ exome
AF:
0.000421
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000210
Gnomad4 OTH exome
AF:
0.000364
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152282
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000213
Hom.:
0
Bravo
AF:
0.000317
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000359
AC:
3
ExAC
AF:
0.000141
AC:
17
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000600
EpiControl
AF:
0.000474

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 12, 2021The c.325G>A (p.D109N) alteration is located in exon 3 (coding exon 2) of the ZNF134 gene. This alteration results from a G to A substitution at nucleotide position 325, causing the aspartic acid (D) at amino acid position 109 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.7
DANN
Benign
0.97
DEOGEN2
Benign
0.0094
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.0016
N
LIST_S2
Benign
0.15
T
M_CAP
Benign
0.0010
T
MetaRNN
Benign
0.057
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.65
N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.73
N
REVEL
Benign
0.068
Sift
Benign
0.40
T
Sift4G
Benign
0.34
T
Polyphen
0.24
B
Vest4
0.12
MVP
0.42
MPC
0.041
ClinPred
0.013
T
GERP RS
-0.43
Varity_R
0.019
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201845735; hg19: chr19-58131812; API